Skip to main content
Equibles

JANUS HENDERSON GROUP PLC

Position in RAPP — Rapport Therapeutics, Inc.

CIK 1274173 LONDON, X0
Back to RAPP Full portfolio

Position in RAPP

as of Mar 31, 2026 · filed May 18, 2026
Position Value
$431,802
+$13,110 QoQ
Shares Held
13,800
0.0% QoQ
Ownership
0.029%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2025
2 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in RAPP Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

JANUS HENDERSON GROUP PLC holds $15,214,395,751 across 183 Biotechnology names. RAPP ranks #144 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ARGX
Argenx SE
 2,541,732 $1,856,099,791
2 PRAX
Praxis Precision Medicines, Inc.
 3,458,863 $1,114,411,067
3 MDGL
Madrigal Pharmaceuticals, Inc.
 2,018,647 $1,056,701,142
4 BBIO
BridgeBio Pharma, Inc.
 13,179,013 $978,673,503
5 PCVX
Vaxcyte, Inc.
 16,575,875 $963,224,094
6 VRTX
Vertex Pharmaceuticals Inc / Ma
 2,131,527 $951,812,064
7 RVMD
Revolution Medicines, Inc.
 9,766,496 $949,791,733
8 MIRM
Mirum Pharmaceuticals, Inc.
 6,945,813 $641,654,204

All Filings in RAPP

Export CSV
2 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $431,802 13,800
2025-12-31 $418,692 13,800